Match Document Document Title
US20130287840 Bulk Enteric Capsule Shells  
The present disclosure relates to aqueous compositions for use in the manufacture of capsule shells endowed with bulk enteric properties. The present disclosure also relates, in part, to aqueous...
US20120308627 LIQUID-FILLED PROTEIN-PHOSPHATIDIC ACID CAPSULE DISPERSIONS  
The present invention generally relates to the field of membranes. In particular, the present invention relates to a composition comprising bodies surrounded by a membrane. The composition are for...
US20110002984 FORMULATIONS COMPRISING EXINE SHELLS  
A formulation containing an active substance encapsulated within an exine shell of a naturally occurring spore, together with a protective additive which is also encapsulated within the exine shell.
US20130040817 CAPSULE COMPRISING ACTIVE INGREDIENT  
The present invention relates to a capsule with a core/shell structure, comprising a core which comprises at least one sparingly water-soluble or water-insoluble organic active ingredient, to a...
US20150110864 NOVEL ANTITUMOR AGENT COMPRISING COMBINATION OF THREE AGENTS  
A primary object of the present invention is to provide a novel combination therapy that exhibits a notable antitumor effect. As means for achieving the object, an antitumor agent comprising a...
US20150235002 Method and System to Provide Personalized Pharmaceutical Compositions and Dosages  
Provided is a method for assessing cardiovascular risk in Metabolic Syndrome and Type 2 Diabetes patients. The method involves obtaining data from a Type 2 diabetes patient or a Metabolic Syndrome...
US20080044442 Container for an Inhalation Anesthetic  
The specification and drawings describe and show one preferred embodiment or a small number of preferred embodiments of the present invention in the form of a container constructed from or lined...
US20100143461 PALONOSETRON FORMULATION  
The present invention provides solid oral formulations of palonosetron or salts thereof.
US20120237593 Formulations of Guanylate Cyclase C Agonists and Methods of Use  
The invention provides low-dose formulations of guanylate cyclase-C (“GCC”) agonist peptides and methods for their use. The formulations of the invention can be administered either alone or in...
US20070110817 Biological active blood serum obtained by electrostimulation  
The present invention relates to a method for preparing a blood serum product, the blood serum product and a pharmaceutical composition comprising said blood serum product as well as uses thereof...
US20060153911 Method for preserving reduced coenzyme Q10  
The present invention has its object to provide a method for stably preserving a capsule containing reduced coenzyme Q10, which is useful as foods, functional nutritive foods, specific health...
US20120114749 COMPOSITIONS AND METHODS FOR DELIVERY OF EMBOLICS  
Described herein are compositions comprising one or more embolics attached to an inert, dissolvable matrix as well as kits comprising these novel embolic formulations. Also described are methods...
US20140377341 CELL LINES AND THEIR USE IN ENCAPSULATED CELL BIODELIVERY  
The present invention relates to generation of cell lines expressing recombinant proteins for use in naked and encapsulated cell biodelivery of secreted therapeutic molecules. In one embodiment...
US20120027847 CELL LINES AND THEIR USE IN ENCAPSULATED CELL BIODELIVERY  
The present invention relates to generation of cell lines expressing recombinant proteins for use in naked and encapsulated cell biodelivery of secreted therapeutic molecules. In one embodiment...
US20070134299 Method and formula for prevention of cold and flu and suppression of related symptoms  
The present invention generally relates to methods, compositions and systems for preventing the common cold and flu, for reducing the duration of common colds and flu, for reducing the severity of...
US20070134315 Orally administrable extended release pellet and tablet formulations of a highly water soluble compound  
Pharmaceutical compositions comprising an extended release formulation of active compounds effective in the treatment of various pathological conditions are provided. More particularly, the...
US20140199384 Facile Route to the Synthesis of Resorcinarene Nanocapsules  
Described is a direct method for the fabrication of resorcinarene nanocapsules by photopolymerization of compounds of formula (I), such as resorcinarene tetraalkene tetrathiol (RTATT), in the...
US20110150987 MUCOADHESIVE PARTICULATE FORMULATION FOR INDUCING ANTIGEN-SPECIFIC IMMUNE TOLERANCE  
The present invention relates to a mucoadhesive composition, adapted for preventing and/or treating a pathological reaction of the immune system of an individual, by inducing a specific tolerance...
US20050037064 Heteroxylan film-forming composition for making capsules and resulting capsules  
A heteroxylan composition for preparing capsules or tablets, in particular soft capsules or hard tablets, the composition containing at least a heteroxylan compound, at least a softening agent,...
US20070128272 Multi-vitamin and mineral supplement  
A nutritional solid oral dosage form for administering a calcium nutrient with an iron nutrient includes enterically coated particles, granules or pellets containing a calcium nutrient. An iron...
US20050129755 Ingestible capsules containing ethanol  
An ingestible capsule containing substantially pure ethanol provided for medicinal or recreational purposes.
US20120301538 PHARMACEUTICAL COMPOSITIONS FOR THE STIMULATION OF STEM CELLS  
The invention relates to a human or veterinary pharmaceutical composition (B) for the stimulation of stem cells, comprising at least two stem-cells-stimulating-agents and at least one...
US20110253633 CATANIONIC VESICLES, PROCESS FOR PREPARING SAME AND APPLICATIONS THEREOF  
Catanionic vesicles, the walls of which are constituted of a mixture of surfactants of opposite charges. Process for preparing same and uses thereof, especially in the field of pharmacy or...
US20060247234 Compositions containing micronized tanaproget prepared by wet granulation  
Compositions, preferably pharmaceutical compositions, containing micronized tanaproget, or pharmaceutically acceptable salt thereof, microcrystalline cellulose, croscarmellose sodium, sodium...
US20090304785 ESCALATING DOSING REGIMEN FOR EFFECTING WEIGHT LOSS AND TREATING OBESITY  
The present invention is drawn to novel topiramate compositions as well as methods for effecting weight loss, e.g., in the treatment of obesity and related conditions, including conditions...
US20060188563 Medicinal oral preparations for colon delivery, medicinal oral preparations for treating colon cancer and medicinal oral preparations for treating colitis  
A medicinal oral preparation to be delivered to the large intestine comprising a core containing a pharmacologically active ingredient, an inner layer containing one or more cationic polymers and...
US20080003278 Food products and dietary supplements for improving mental performance  
Formulas for producing compositions for the dietary supplement and nutraceutical products, containing virgin olive oil, vitamins, substances as vincamine, vinpocetine or vinburnine, as well as...
US20050106232 Biocompatible composite capsules  
The invention relates to a method of preparing composite capsules by means of interfacial polycondensation in a dispersed medium of at least two different monomers. The invention is characterised...
US20060240095 Pharmaceutical composition comprising a combination of metformin and a statin  
A pharmaceutical composition comprising: (i) metformin, optionally in the form of one of its pharmaceutically acceptable salts, (ii) a statin, optionally in the form one of its pharmaceutically...
US20130323304 Methods For Enhancing The Release And Absorption of Water Insoluble Active Agents  
Methods for enhancing the release and/or absorption of poorly water soluble active agents are described herein. The method involves dissolving, melting, or suspending a poorly water soluble active...
US20060165775 Capsule and film-forming composition comprising gum arabic  
A capsule for oral delivery of a composition comprises 60% to 95% by weight of gum arabic and to the remainder a water-soluble polymer, a hydrocolloid and a plasticizer. The proportion of gum...
US20140154309 SOLID GANAXOLONE COMPOSITIONS AND METHODS FOR THE MAKING AND USE THEREOF  
In certain embodiments, the invention is directed to composition comprising stable particles comprising ganaxolone, wherein the volume weighted median diameter (D50) of the particles is from about...
US20070104659 Capsule-containing oral composition  
The present invention provides an oral composition comprising capsule particles that are easily breakable to thereby readily release and distribute the capsule contents when used, while leaving...
US20130195972 PHARMACEUTICAL COMPOSITIONS COMPRISING EPA AND A CARDIOVASCULAR AGENT AND METHODS OF USING THE SAME  
The present invention relates to, inter alia, pharmaceutical compositions comprising EPA and one or more cardiovascular agents, and to therapeutic methods for treating various diseases and...
US20120121698 PHARMACEUTICAL COMPOSITIONS COMPRISING EPA AND A CARDIOVASCULAR AGENT AND METHODS OF USING THE SAME  
The present invention relates to, inter alia, pharmaceutical compositions comprising EPA and one or more cardiovascular agents, and to therapeutic methods for treating various diseases and...
US20120093922 PHARMACEUTICAL COMPOSITIONS COMPRISING EPA AND A CARDIOVASCULAR AGENT AND METHODS OF USING THE SAME  
The present invention relates to, inter alia, pharmaceutical compositions comprising EPA and one or more cardiovascular agents, and to therapeutic methods for treating various diseases and...
US20070141137 Stable capsule preparation  
A capsule in which an unstable active ingredient has been stabilized is obtained by lowering the moisture content of a solid preparation (granules, subtilis, tablets, etc.) containing a chemical...
US20080107725 Pharmaceutical Solid Dosage Forms Comprising Amorphous Compounds Micro-Embedded in Ionic Water-Insoluble Polymers  
The present invention provides novel pharmaceutical solid dosage forms for oral administration comprising a therapeutically effective amount of an unstable crystalline form or an amorphous form of...
US20110142924 Irilis biopreparation based on bacillus-strain bacteria, bacillus subtilis and bacillus licheniformis contained therein  
A bioengineering, in particular to develop novel probiotic preparations based on Bacillus-strain bacteria, which can be used for preventing and treating infectious diseases and disbiosis of a...
US20090123386 Abuse Resistant Capsules  
Hard shell capsules filled with a pharmaceutical medicament and at least one modifier, selected to prevent abuse of the medicament are described. The modifier may have a high melting point, and...
US20070224215 Brown seaweed extracts in capsules consisting of broad-spectrum freeze dried antioxidant concentrates, Fucoidan, crystalloidals, Mangosteen, hyaluronic acid, alpha lipoic acid, green tea extract, vitamin C, and black pepper extract with delivery systems for utilization of nutrients  
Method of making a Fucoidan Brown seaweed capsule with one or more or more of the following ingredients: freeze dried white and concord grape polyphenol carotenoid concentrate, mangosteen, freeze...
US20100285077 COSMETIC COMPOSITION COMPRISING HYDROXYMETHIONINE AND 3-AMINOPROPANESULFONIC ACID  
The present invention relates to cosmetic compositions comprising an association of hydroxymethionine and 3-aminopropanesulfonic acid, and a cosmetic method for the skin. These compositions are...
US20100129440 EMBRYONIC-LIKE STEM CELLS DERIVED FROM ADULT HUMAN PERIPHERAL BLOOD AND METHODS OF USE  
The present invention is related generally to embryonic-like stem cells isolated from adult human peripheral blood, designated herein as peripheral blood-stem cells (PB-SC), which display the...
US20140366217 MUTANTS OF ALPHA-AMYLASE INHIBITORS ISOLATED FROM PHASEOLUS VULGARIS CAPABLE OF CONTROLLING INSECT PESTS, COMPOSITIONS CONTAINING THESE MUTANTS AND METHOD OF USING THE SAME  
The present invention relates to the field of insect pests control, using methods and compositions which comprise of alpha-amylase analogous mutant inhibitors (αAIs). More specifically, the...
US20120039996 USES OF RED YEAST RICE IN TREATING DENGUE VIRUS INFECTION  
This invention provides a method of using red yeast rice fermented product to treat a subject having a disease caused by dengue virus. In one embodiment, the red yeast rice is prepared with the...
US20140377170 VIRION-DERIVED NANOSPHERES FOR SELECTIVE DELIVERY OF THERAPEUTIC AND DIAGNOSTIC AGENTS TO CANCER CELLS  
The invention relates to methods for producing papilloma-derived nanosphere particles that contain therapeutic, diagnostic, or other agents. The invention also provides nanosphere particle...
US20090263475 DEXLANSOPRAZOLE COMPOSITIONS  
Premixes of dexlansoprazole with pharmaceutical excipients, processes for preparing premixes, pharmaceutical formulations containing the premixes, and their use in treatment of erosive esophagitis...
US20140234405 INSULIN INDEPENDENCE AMONG PATIENTS WITH DIABETES UTILIZING A PPI IN COMBINATION WITH AN IMMUNE TOLERANCE AGENT  
To date, no immune tolerance agent or combination of immune tolerance agents has been able to sustain insulin-independence among type 1 diabetes patients. This patent provides methods and...
US20140322312 PROTON PUMP-INHIBITOR-CONTAINING CAPSULES WHICH COMPRISE SUBUNITS DIFFERENTLY STRUCTURED FOR A DELAYED RELEASE OF THE ACTIVE INGREDIENT  
An oral pharmaceutical composition comprises multiple populations of at least one of beads, pellets, tablets and granules provided in a capsule, the composition comprising: a first population of a...
US20110091536 COMPOSITIONS COMPRISING EUPHORBIA PROSTRATA AND PROCESS OF PREPARATION THEREOF  
Oral pharmaceutical compositions comprising dry extract of Euphorbia prostrata from about 0.1% to about 99% by weight wherein the effective average particle size of the dry extract of Euphorbia...